EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA--(Marketwire - Sep 13, 2012) - Sunshine Heart, Inc. (
Mr. Callinan said, "I welcome John to the board. With his outstanding experience in our industry, he is ideally qualified to lead the Company through its next stage of development. I have been privileged to be part of Sunshine Heart for the past four years which have seen many changes, an important one of which has been the Company's transition to the U.S. and its listing on NASDAQ. It is now time to change the balance of our board and to appoint a U.S. based Chairman. John Erb has extensive experience in the cardiovascular industry, merger and acquisition transactions, and serves as a Board member and Chairman of NASDAQ, ASX and private companies. He is clearly very well-prepared to guide Sunshine Heart through its next phase of development."
Mr. Erb currently serves as the Chairman of Vascular Solutions (
Sunshine Heart CEO, Dave Rosa, paid tribute to Mr. Callinan's contribution to the Company and to the board, "Over the past four years, Mr. Callinan has overseen a number of major milestones. I personally want to thank Nick for his support, guidance and mentorship over the past three years. We believe we are now well prepared to enter into our next phase as a Company and wish Nick all the best."
As part of this transition, Mr. Callinan will remain on the Board through the end of 2012.
About the C-Pulse® Heart Assist System
The C-Pulse Heart Assist System, or C-Pulse System, an investigational device in the United States, Canada and countries that do not recognize the CE mark approval, utilizes the scientific principles of intra-aortic balloon counter-pulsation applied in an extra-aortic approach to assist the left ventricle by reducing the workload required to pump blood throughout the body, while increasing blood flow to the coronary arteries. Operating outside the patient's bloodstream, the extra-aortic approach of the C-Pulse technology offers greater flexibility, allowing patients to safely disconnect to have intervals of freedom to perform certain activities such as showering. The C-Pulse System may help maintain the patient's current condition and, in some cases, reverse the heart failure process, thereby potentially preventing the need for later stage heart failure therapies, such as left ventricular assist devices (LVADs), artificial hearts or transplants.
Caution: Investigational device, limited by Federal (or United States) Law to Investigational use.
About Sunshine® Heart
Sunshine Heart, Inc. (
Chief Financial Officer
+1 952 345 4200